ROG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ROG is not a good buy right now. Despite a longer-term bullish moving-average structure, near-term momentum is deteriorating (negative and expanding MACD histogram), price is below the pivot level, and insider selling has surged. Options positioning looks call-heavy but actual option trading activity is minimal, so it’s not a strong sentiment confirmation. With earnings coming on 2026-02-23 and recent profit/margin declines, I’d avoid initiating a new position at this price and treat it as a hold/avoid rather than a buy.
Trend/Momentum: The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), which supports a constructive medium-term trend. However, momentum is weakening: MACD histogram is negative (-0.435) and expanding lower, signaling increasing bearish pressure. RSI_6 at ~46.97 is neutral, offering no oversold bounce signal. Key Levels: Current price ~96.36 is below the pivot (98.385), implying the stock is trading in a weaker zone. Near-term support is S1 ~94.882 (then S2 ~92.718). Resistance is near the pivot 98.385 and R1 ~101.888. Implication: The setup is mixed—trend up, momentum down. With price under the pivot and MACD worsening, the near-term risk skews to a test of support before a cleaner entry forms.
Pattern-based projection indicates upside bias over the next week/month (+4.6% next week, +12.86% next month), suggesting potential continuation if support holds.
Medium-term MA structure remains bullish (SMA_5 > SMA_20 > SMA_200).
Upcoming earnings (QDEC
on 2026-02-23 after hours could act as a catalyst if management shows reacceleration in Auto/Industrial orders.
Momentum deterioration: MACD histogram is negative and worsening, increasing odds of near-term downside.
Insider activity: Insiders are selling, with selling amount up ~372.78% over the last month (clear negative signal).
Profitability weakening: latest reported quarter shows declining net income/EPS and gross margin YoY.
No supportive news flow in the past week; no obvious near-term positive catalyst before earnings.
Latest quarter provided: 2025/Q3. Revenue grew to $216M (+2.71% YoY), but profitability weakened: net income fell to $8.6M (-19.63% YoY) and EPS to $0.48 (-17.24% YoY). Gross margin declined to 33.47% (-5.02% YoY). Takeaway: modest top-line growth but deteriorating margins/earnings—fundamentals are not currently accelerating.
Recent ROG-specific analyst update: On 2026-01-20, B. Riley raised its price target to $127 from $105 while maintaining a Neutral rating, citing potential fractional upside to estimates if Auto/Industrial orders improve and expecting results roughly in line with consensus as management implements reacceleration initiatives. Note: Several other analyst notes in the feed reference Roche (not Rogers Corp) and appear unrelated to ROG. Wall Street pros/cons view (from available ROG-relevant note): Pros—potential demand recovery in Auto/Industrial and operational initiatives under new management; higher target suggests upside potential. Cons—rating remains Neutral (not a clear conviction buy) and near-term results are expected to be merely in line, implying limited immediate catalyst.
